Tempest Therapeutics, Inc. Share-based Payment Arrangement, Noncash Expense
Tempest Therapeutics, Inc. (TPST) reported Share-based Payment Arrangement, Noncash Expense of $1.26 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2018-11-09
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $347.00K, a 24.40% decline year-over-year.
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-06-30 was $530.00K, a 88.37% decline year-over-year.
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-03-31 was $382.00K, a 71.91% decline year-over-year.
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-12-31 was $516.00K, a 47.88% decline year-over-year.
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $6.89M, a 25.20% decline from fiscal 2016.
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $9.21M, a 52.35% decline from fiscal 2015.
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2015 was $19.34M, a 55.86% increase from fiscal 2014.
- Tempest Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2014 was $12.41M, a 143.56% increase from fiscal 2013.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 15 month | Share-based Payment Arrangement, Noncash Expense 18 month | Share-based Payment Arrangement, Noncash Expense 21 month | Share-based Payment Arrangement, Noncash Expense 24 month | Share-based Payment Arrangement, Noncash Expense 27 month | Share-based Payment Arrangement, Noncash Expense 30 month | Share-based Payment Arrangement, Noncash Expense 33 month | Share-based Payment Arrangement, Noncash Expense 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $877.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.26M 10-Q · filed 2018-11-09 | $1.77M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2018-06-30 | $530.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $912.00K 10-Q · filed 2018-08-09 | $1.43M derived: sum of 3 quarters · filed 2018-08-09 | $1.89M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2018-03-31 | $382.00K 10-Q · filed 2018-05-03 | $898.00K derived: sum of 2 quarters · filed 2018-05-03 | $1.36M derived: sum of 3 quarters · filed 2018-11-09 | $5.92M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2017-12-31 | $516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $975.00K derived: sum of 2 quarters · filed 2018-11-09 | $5.53M derived: sum of 3 quarters · filed 2018-11-09 | $6.89M 10-K · filed 2018-03-15 | ||||||||
| 2017-09-30 | $459.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $5.02M derived: sum of 2 quarters · filed 2018-11-09 | $6.38M 10-Q · filed 2018-11-09 | $7.37M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||
| 2017-06-30 | $4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $5.92M 10-Q · filed 2018-08-09 | $6.91M derived: sum of 3 quarters · filed 2018-08-09 | $9.42M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||
| 2017-03-31 | $1.36M 10-Q · filed 2018-05-03 | $2.35M derived: sum of 2 quarters · filed 2018-05-03 | $4.86M derived: sum of 3 quarters · filed 2018-05-03 | $7.02M derived: sum of 4 quarters · filed 2018-05-03 | ||||||||
| 2016-12-31 | $990.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $3.50M derived: sum of 2 quarters · filed 2018-03-15 | $5.66M derived: sum of 3 quarters · filed 2018-03-15 | $9.21M 10-K · filed 2018-03-15 | ||||||||
| 2016-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $4.67M derived: sum of 2 quarters · filed 2017-11-02 | $8.22M 10-Q · filed 2017-11-02 | $13.14M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2016-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $5.72M 10-Q · filed 2017-08-03 | $10.64M derived: sum of 3 quarters · filed 2018-03-15 | $14.34M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2016-03-31 | $3.55M 10-Q · filed 2017-05-09 | $8.47M derived: sum of 2 quarters · filed 2018-03-15 | $12.17M derived: sum of 3 quarters · filed 2018-03-15 | $16.52M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||
| 2015-12-31 | $4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $8.62M derived: sum of 2 quarters · filed 2018-03-15 | $12.97M derived: sum of 3 quarters · filed 2018-03-15 | $19.34M 10-K · filed 2018-03-15 | ||||||||
| 2015-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $8.05M derived: sum of 2 quarters · filed 2016-11-03 | $14.42M 10-Q · filed 2016-11-03 | $20.79M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2015-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $10.72M 10-Q · filed 2016-08-04 | $17.09M derived: sum of 3 quarters · filed 2017-03-02 | $20.04M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2015-03-31 | $6.37M 10-Q · filed 2016-05-05 | $12.74M derived: sum of 2 quarters · filed 2017-03-02 | $15.69M derived: sum of 3 quarters · filed 2017-03-02 | $17.91M derived: sum of 4 quarters · filed 2017-03-02 | ||||||||
| 2014-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $9.32M derived: sum of 2 quarters · filed 2017-03-02 | $11.54M derived: sum of 3 quarters · filed 2017-03-02 | $12.41M 10-K · filed 2017-03-02 | ||||||||
| 2014-09-30 | $2.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $5.17M derived: sum of 2 quarters · filed 2015-11-05 | $6.04M 10-Q · filed 2015-11-05 | $7.30M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2014-06-30 | $2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $3.08M 10-Q · filed 2015-08-10 | $4.35M derived: sum of 3 quarters · filed 2016-02-26 | $5.96M derived: sum of 4 quarters · filed 2016-02-26 | ||||||||
| 2014-03-31 | $867.00K 10-Q · filed 2015-05-11 | $2.13M derived: sum of 2 quarters · filed 2016-02-26 | $3.75M derived: sum of 3 quarters · filed 2016-02-26 | $5.12M derived: sum of 4 quarters · filed 2016-02-26 | $7.69M 10-Q · filed 2014-05-08 | |||||||
| 2013-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.88M derived: sum of 2 quarters · filed 2016-02-26 | $4.26M derived: sum of 3 quarters · filed 2016-02-26 | $5.09M 10-K · filed 2016-02-26 | $6.82M 10-K · filed 2014-02-27 | |||||||
| 2013-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.99M derived: sum of 2 quarters · filed 2014-11-10 | $3.83M 10-Q · filed 2014-11-10 | $4.35M derived: sum of 4 quarters · filed 2015-03-16 | $5.56M 10-Q · filed 2013-11-13 | |||||||
| 2013-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.21M 10-Q · filed 2014-08-07 | $2.73M derived: sum of 3 quarters · filed 2015-03-16 | $3.03M derived: sum of 4 quarters · filed 2015-03-16 | $3.94M 10-Q · filed 2013-08-13 | |||||||
| 2013-03-31 | $837.00K 10-Q · filed 2014-05-08 | $1.36M derived: sum of 2 quarters · filed 2015-03-16 | $1.66M derived: sum of 3 quarters · filed 2015-03-16 | $1.96M derived: sum of 4 quarters · filed 2015-03-16 | $2.56M 10-Q · filed 2013-05-15 | |||||||
| 2012-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $823.00K derived: sum of 2 quarters · filed 2015-03-16 | $1.12M derived: sum of 3 quarters · filed 2015-03-16 | $1.38M 10-K · filed 2015-03-16 | $1.73M 10-K · filed 2013-02-25 | |||||||
| 2012-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $600.00K derived: sum of 2 quarters · filed 2013-11-13 | $859.00K 10-Q · filed 2013-11-13 | $1.21M 10-Q · filed 2012-11-13 | ||||||||
| 2012-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $559.00K 10-Q · filed 2013-08-13 | $905.00K 10-Q · filed 2012-08-14 | |||||||||
| 2012-03-31 | $259.00K 10-Q · filed 2013-05-15 | |||||||||||
| 2011-12-31 | $346.00K 10-K · filed 2014-02-27 | |||||||||||
| 2011-09-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13 | $40.00K 10-Q · filed 2012-11-13 | ||||||||||
| 2011-06-30 | $9.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |